Dr Alexander Kharlamov
Consulting Editor: Alexander Kharlamov (M.D., Ph.D)
Independent Researcher in Interventional Vascular Medicine and Nanobiotechnology, De Haar Research Foundation, Rotterdam, the Netherlands
Dr. Kharlamov has 19 years of the clinical experience in general cardiology (since 1996), 14 years of the translational research in nanomedicine and biomedical engineering (since 2001), and about 8 years of the bench-to-bedside studies in interventional cardiology (since 2007) including imaging, vascular biology and pathology, RTD of medical devices (bioresorbable scaffolds and stents). He was born in NY, NY in 1980 having American, Dutch and British roots, move to Russia, and has received his M.D. (Doctor of Medicine) cum laude in 2005 from Ural Medical University (Yekaterinburg, Russia). After finishing his internship in general cardiology in 2007 at the Department of Internal Medicine in Ural Institute of Cardiology (mentor - Prof. Jan Gabinsky, Yekaterinburg, Russia) he started as a physician and translational researcher in the field of interventional cardiology and nanobiotechnologies. The main research direction of the group now is an RTD of the new uniform multifunctional nanoparticles for theranostics of atherosclerosis - both plasmonic photothermal therapy (PPTT) and imaging of compromised coronary arteries. He is an inventor of the revolutionary application of PPTT for the management of atherosclerosis which has a potential to replace conventional stenting and CABG. He has received his Ph.D. from Ural Medical University in 2011. Since 2007-2009 he has been working as a research fellow in some institutes in the Netherlands (UMC St Radboud, Nijmegen; UMCG, Groningen; Erasmus MC, Rotterdam including mentorship of the renowned Prof. Patrick Serruys). He is an author of more than 60 articles and some grant proposals for the European Commission, and has received for his research work some national and international awards.